PROCEPT BioRobotics Corporation Deferred Tax Assets, Operating Loss Carryforwards
PROCEPT BioRobotics Corporation (PRCT) had Deferred Tax Assets, Operating Loss Carryforwards of $109.93 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-02-26
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $109.93M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $96.48M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $80.27M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $65.20M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $109.93M 10-K · filed 2026-02-26 |
| 2024-12-31 | $96.48M 10-K · filed 2026-02-26 |
| 2023-12-31 | $80.27M 10-K · filed 2025-02-27 |
| 2022-12-31 | $65.20M 10-K · filed 2024-02-28 |
| 2021-12-31 | $52.83M 10-K · filed 2023-02-28 |
| 2020-12-31 | $42.33M 10-K · filed 2022-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |